Home Healthcare IT Ureteroscopy Market Size, Global Statistics And Growth Report, 2031

Ureteroscopy Market

Ureteroscopy Market Size, Share & Trends Analysis Report By Product Type (Flexible Ureteroscope, Semi- Rigid Ureteroscope), By Applications (Urolithiasis, Kidney Cancer, Urinary Stricture, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI55045DR
Study Period 2019-2031 CAGR 4.45%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 857.4 Million
Forecast Year 2031 Forecast Year Market Size USD 1322.4 Million
Largest Market North America Fastest Growing Market Asia Pacific
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global ureteroscopy market size was valued at USD 857.4 million in 2023. It is projected to reach USD 1,322.4 million by 2031, registering a CAGR of 4.4% during the forecast period (2023-2031). 

The global market expansion can be attributed to the rising prevalence of urological disorders and the advancements in minimally invasive surgical procedures. Ureteroscopes are a type of endoscopic instrument that is employed in the medical procedure known as ureteroscopy. These medical devices are employed to treat and diagnose disorders related to the kidneys and the upper urinary system. Ureteroscopy is a medical technique used to diagnose and treat infections within the urinary tract, specifically within the ureters and kidneys. It involves using a specialized tool called a ureteroscope, a thin, flexible, or rigid tube with a camera and light source at its tip. This ureteroscope is inserted into the urinary tract through the urethra, bladder, and then into the ureter to access the kidneys.

Market Dynamics

Global Ureteroscopy Market Drivers:

Increasing Prevalence of Kidney Stones 

The increasing occurrence of kidney stones, a prevalent urological condition that affects a sizeable section of the world's population, is driving the significant expansion of the ureteroscopy market. Diets high in specific minerals, poor hydration, sedentary lifestyles, and genetic predispositions contribute to this rising prevalence. As a result of the increase in kidney stone cases, there is a greater need for efficient diagnostic and therapeutic options for both individuals and healthcare systems. Ureteroscopy is a less intrusive and extremely efficient therapy option for kidney stones as the incidence of these stones rises. The therapy allows urologists to reach kidney and ureter stones directly through a flexible ureteroscope equipped with state-of-the-art imaging technology. Notably, ureteroscopy has many benefits over conventional surgical procedures, including less patient pain, shorter hospital stays, and quicker recovery times.

Furthermore, ureteroscopy is a favored option for patients and medical professionals due to its adaptability in treating stones of all sizes and compositions, even in difficult instances. Kidney stones are rising globally due to changing dietary and lifestyle habits, which is projected to drive strong growth in the ureteroscopy market. Unquestionably, ureteroscopy plays a crucial role in urological care, and its importance in tackling the epidemic of kidney stones emphasizes its function as a motivating factor behind expansion and development.

Global Ureteroscopy Market Restraints:

Cost of Equipment and Training

A key barrier to expanding the ureteroscopy business is the necessary tools and training costs. Specialized equipment is required for ureteroscopy treatments, including flexible ureteroscopes and cutting-edge imaging technology, which can be expensive to purchase and maintain. Comprehensive training programs are also necessary because ureteroscopy requires highly skilled and knowledgeable medical professionals. This cost factor may be a major obstacle, especially for smaller clinics, healthcare facilities, or geographic areas with little funding. Some healthcare providers might be reluctant to offer ureteroscopy as a standard treatment option due to the initial expenditure necessary to acquire the appropriate infrastructure and equipment and continuing maintenance costs.

Additionally, the ongoing training and skill development requirement among medical staff can increase the budgetary burden. As a result, the expense of tools and training may prevent ureteroscopy treatments from being used widely, which would hurt the market's expansion. Expanding training programs, looking into more affordable equipment alternatives, and encouraging healthcare facilities to invest in ureteroscopy technology could all help alleviate this restriction, making this valuable technique more accessible to patients needing efficient urological care.

Global Ureteroscopy Market Opportunities:

Technological Advancements and Innovation

The landscape of urological care has substantially improved thanks to technological developments and innovation, redefining the ureteroscopy market. Advancements in equipment and imaging technologies have improved precision and accuracy, improved patient outcomes, heightened success rates, reduced post-operative discomfort, and expedited recovery periods. The discomfort experienced by patients during treatments is also being reduced through the development of smaller and more flexible ureteroscopes, making them more patient-friendly.

Additionally, expanding the therapy scope to include problems beyond kidney stones enhances the market's potential for application, attracting a wider range of patients. Integrating robotics and artificial intelligence is elevating the level of precision and automation in ureteroscopy. In addition, telemedicine and remote guidance capabilities are broadening access to specialized care, allowing patients in underserved areas to receive expert consultation during procedures. These advancements improve patient care, drive market growth, attract investments, and make ureteroscopy a compelling option for patients and healthcare providers seeking minimally invasive urological solutions.

Regional Analysis

Based on region, the global ureteroscopy market analysis is conducted across North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.

North America Dominates the Global Market

North America is the most significant global market shareholder and is expected to grow significantly over the forecast period. North America holds most of the market share, particularly the United States, which has historically dominated the ureteroscopy market due to a combination of factors. First, the region boasts an advanced healthcare infrastructure with state-of-the-art medical facilities and cutting-edge technology. This infrastructure facilitates the widespread adoption of advanced medical procedures like ureteroscopy. North America exhibits a relatively high prevalence of urological conditions, such as kidney stones and kidney cancer, which fuels the demand for urological procedures, including ureteroscopy. The region's healthcare system is well-prepared to address these conditions, further contributing to the dominance of ureteroscopy in the market.

Additionally, technological advancements are significant, with North America often leading in medical technology development. Urology practices in the region have access to the latest innovations in endoscopic equipment, imaging techniques, and surgical instruments, making ureteroscopy more effective and efficient. Moreover, high healthcare spending, comprehensive insurance coverage, a commitment to research and innovation, a robust medical education system producing skilled urologists, and the attraction of medical tourists all contribute to North America's prominence in the ureteroscopy market. However, market dynamics can evolve, influenced by various factors, and other regions may also make advancements in healthcare infrastructure and technology, potentially impacting North America's dominance in the future.

In Asia-Pacific, the ureteroscopy market is witnessing robust growth due to a convergence of factors. Key among these is the substantial improvement in healthcare infrastructure in many Asia-Pacific countries, encompassing the expansion of healthcare facilities, the integration of cutting-edge medical equipment, and comprehensive training of healthcare professionals. This enhanced infrastructure has considerably increased accessibility to urological procedures like ureteroscopy, thereby driving demand for these services. Similarly, there is a noticeable surge in healthcare awareness among the Asia-Pacific population, leading to a proactive approach towards seeking medical care and preventative measures. This heightened awareness propels the demand for diagnostic and treatment procedures like ureteroscopy.

The Asia-Pacific region grapples with a significant prevalence of urological illnesses, such as urinary tract infections and kidney stones, further augmenting the market's growth. Lifestyle changes, population growth, and dietary habits increase the incidence of these urological disorders. In addition, technological advancements are also pivotal in the Asia-Pacific ureteroscopy market's expansion. Many countries in the region are adopting state-of-the-art endoscopic equipment, advanced imaging systems, and innovative surgical techniques. These advancements enhance ureteroscopy's efficiency, invasiveness, and safety, making it an appealing choice for patients and healthcare providers.

Report Scope

Report Metric Details
By Product Type
  1. Flexible Ureteroscope
  2. Semi- Rigid Ureteroscope
By Applications
  1. Urolithiasis
  2. Kidney Cancer
  3. Urinary Stricture
  4. Others
By End-User
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Others
Company Profiles Stryker Corporation Hoya Corporation Olympus Corporation Cliniva Healthcare OTU Medical STERIS plc Advin Health Care KARL STORZ SE & Co. KG Richard Wolf GmbH Boston Scientific Corporation
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Singapore Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global ureteroscopy market is segmented based on product type, application, and end-user.

Based on product type, the global ureteroscopy market is segmented into flexible ureteroscopes and semi-rigid ureteroscopes.

The flexible ureteroscope dominates the global market and is expected to grow significantly over the forecast period. Due to its exceptional advantages, Flexible Ureteroscopes have a significant market share in the urology sector. Patients prefer them because of their minimally invasive nature, which causes less trauma and discomfort during procedures. Similarly, flexible ureteroscopes are versatile, allowing them to be used in various urological procedures ranging from kidney stone removal to tumor and stricture treatment.

Semi-rigid ureteroscopes are highly sought in urology because of their longevity, stiffness, and compatibility with various accessories. These attributes make them suitable for addressing specific clinical scenarios and accommodating the preferences of urologists. They are frequently used in conjunction with flexible ureteroscopes.

Based on application, the global ureteroscopy market is divided into urolithiasis, kidney cancer, urinary stricture, and others.

The urinary stricture segment owns the highest market share and is expected to expand significantly during the forecast period. Urinary strictures are increasing the demand for ureteroscopy due to their diagnostic and treatment relevance. Ureteroscopy offers an effective and minimally invasive approach to diagnosis and treatment, making it a preferred choice for many patients. The need for this therapy is further augmented by advancements in technology and an increasing awareness among individuals. The demand for ureteroscopy in the management of urinary strictures is also influenced by patient desire for less intrusive treatment choices.

Based on application, the global ureteroscopy market is fragmented into hospitals, ambulatory surgical centers, and others.

The hospital segment is the largest contributor to the market and is expected to expand substantially over the forecast period. Hospitals typically handle a wide range of medical cases, including complex and high-risk procedures. They often have specialized urology departments equipped to handle ureteroscopy for various urological conditions, including kidney stones, kidney cancer, and urinary strictures. Hospitals are more likely to perform ureteroscopy for patients with severe or complicated cases, where immediate access to additional medical resources and specialists is essential.

ASCs focus on providing outpatient surgical procedures in a more cost-effective and convenient setting. Ureteroscopy can be performed in ASCs for less complex cases, such as routine stone removal or diagnostic procedures. ASCs are preferred for their efficiency, reduced wait times, and lower costs compared to hospital settings. Due to these advantages, patients with straightforward urological issues may opt for ASCs for ureteroscopy.

Market Size By Product Type

Recent Developments

  • February 2023- According to a press statement from Boston Scientific Corporation, the FDA approved the LithoVue Elite Single-Use Digital Flexible Ureteroscope System under 510(k) regulation.

Top Key Players

Stryker Corporation Hoya Corporation Olympus Corporation Cliniva Healthcare OTU Medical STERIS plc Advin Health Care KARL STORZ SE & Co. KG Richard Wolf GmbH Boston Scientific Corporation Others

Frequently Asked Questions (FAQs)

What is the estimated growth rate (CAGR) of the ureteroscopy market?
The market size is growing at a CAGR of 4.4% from 2021 to 2031.
North America has the largest share of this market.
Increasing prevalence of kidney stones is the key driver for the growth of this market.
The key players in this market are Stryker Corporation,Hoya Corporation,Olympus Corporation,Cliniva Healthcare,OTU Medical,STERIS plc,Advin Health Care,KARL STORZ SE & Co. KG,Richard Wolf GmbH,Boston Scientific Corporation.
The market size are projected to reach USD 1,322.4 million by 2031.

We are featured on :